Overview

Biolumina is a full-service, global healthcare agency that brings high-science brands to life through omnichannel marketing. It builds brand experiences that go beyond data and use emotional hooks to motivate action, change behavior, and foster brand loyalty. By acting as translational scientists, Biolumina translates complex scientific ideas into clear, compelling creative and brand stories, driven by curiosity and deep customer insights. The company differentiates itself with a strong emphasis on translating scientific content into engaging, emotionally resonant experiences at scale, serving as a partner for high-science brands across channels. Its goal is to move the needle for clients by turning scientific concepts into motivating narratives that change behavior and build long-term loyalty.

Simplify's Take

What believers are saying

• Added clients Bicycle Therapeutics, Nuvation Bio, Zentalis Pharmaceuticals in 2024.
• Headcount grew from 425 to 475 supporting steady organic growth.
• On target for healthy 2025 business with new wins per CEO Kantak.

What critics are saying

• Oncology patent cliffs hit Keytruda in 2028, Opdivo in 2026, concentrating revenue.
• Merck-Seagen 2023 integration cuts client brand teams and agency needs.
• Omnicom merges redundant agencies, pressuring Biolumina post-2024 Rise & Run buy.

What makes Biolumina unique

• Biolumina specializes exclusively in oncology marketing as its core superpower.
• Integrated Rise & Run team enhances customized data-driven healthcare solutions.
• Omnicom Health Group resources enable omnichannel global advertising expertise.

Help us improve and share your feedback! Did you find this helpful?

YesNo